ATAD3A-related Pontocerebellar Hypoplasia: New Patients and Insights into Phenotypic Variability

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2023 Apr 24

PMID 37095554

Authors

Martina Skopkova

Hana Stufkova

Vibhuti Rambani

Viktor Stranecky

Katarina Brennerova

Miriam Kolnikova

Michaela Pietrzykova

Miloslav Karhanek

Lenka Noskova

Marketa Tesarova

Hana Hansikova

Daniela Gasperikova

Affiliations

Soon will be listed here.

Abstract

Background: Pathogenic variants in the ATAD3A gene lead to a heterogenous clinical picture and severity ranging from recessive neonatal-lethal pontocerebellar hypoplasia through milder dominant Harel-Yoon syndrome up to, again, neonatal-lethal but dominant cardiomyopathy. The genetic diagnostics of ATAD3A-related disorders is also challenging due to three paralogous genes in the ATAD3 locus, making it a difficult target for both sequencing and CNV analyses.

Results: Here we report four individuals from two families with compound heterozygous p.Leu77Val and exon 3-4 deletion in the ATAD3A gene. One of these patients was characterized as having combined OXPHOS deficiency based on decreased complex IV activities, decreased complex IV, I, and V holoenzyme content, as well as decreased levels of COX2 and ATP5A subunits and decreased rate of mitochondrial proteosynthesis. All four reported patients shared a strikingly similar clinical picture to a previously reported patient with the p.Leu77Val variant in combination with a null allele. They presented with a less severe course of the disease and a longer lifespan than in the case of biallelic loss-of-function variants. This consistency of the phenotype in otherwise clinically heterogenous disorder led us to the hypothesis that the severity of the phenotype could depend on the severity of variant impact. To follow this rationale, we reviewed the published cases and sorted the recessive variants according to their impact predicted by their type and the severity of the disease in the patients.

Conclusion: The clinical picture and severity of ATAD3A-related disorders are homogenous in patients sharing the same combinations of variants. This knowledge enables deduction of variant impact severity based on known cases and allows more accurate prognosis estimation, as well as a better understanding of the ATAD3A function.

Citing Articles

Mutations in mitochondrial gene and disease, lessons from models.

Brugel M, Kiesel A, Haack T, Peralta S Front Neurosci. 2024; 18:1496142.

PMID: 39605788 PMC: 11599198. DOI: 10.3389/fnins.2024.1496142.

gene variations in a family with Harel-Yoon syndrome.

Zheng Y, Yu X, Zhang T, Hu L, Zhou D, Huang X Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52(6):738-743.

PMID: 38105692 PMC: 10764186. DOI: 10.3724/zdxbyxb-2023-0421.

ATAD3A: A Key Regulator of Mitochondria-Associated Diseases.

Chen L, Li Y, Zambidis A, Papadopoulos V Int J Mol Sci. 2023; 24(15).

PMID: 37569886 PMC: 10419812. DOI: 10.3390/ijms241512511.

References

Harel T, Yoon W, Garone C, Gu S, Coban-Akdemir Z, Eldomery M . Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes. Am J Hum Genet. 2016; 99(4):831-845. PMC: 5065660. DOI: 10.1016/j.ajhg.2016.08.007. View

Frazier A, Compton A, Kishita Y, Hock D, Welch A, Amarasekera S . Fatal perinatal mitochondrial cardiac failure caused by recurrent duplications in the locus. Med. 2021; 2(1):49-73. PMC: 7875323. DOI: 10.1016/j.medj.2020.06.004. View

McKenzie M, Lazarou M, Ryan M . Chapter 18 Analysis of respiratory chain complex assembly with radiolabeled nuclear- and mitochondrial-encoded subunits. Methods Enzymol. 2009; 456:321-39. DOI: 10.1016/S0076-6879(08)04418-2. View

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

Merle N, Feraud O, Gilquin B, Hubstenberger A, Kieffer-Jacquinot S, Assard N . ATAD3B is a human embryonic stem cell specific mitochondrial protein, re-expressed in cancer cells, that functions as dominant negative for the ubiquitous ATAD3A. Mitochondrion. 2012; 12(4):441-8. DOI: 10.1016/j.mito.2012.05.005. View

Abou Tayoun A, Pesaran T, DiStefano M, Oza A, Rehm H, Biesecker L . Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat. 2018; 39(11):1517-1524. PMC: 6185798. DOI: 10.1002/humu.23626. View

Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray J . Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994; 228(1):35-51. DOI: 10.1016/0009-8981(94)90055-8. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

He J, Cooper H, Reyes A, Di Re M, Sembongi H, Litwin T . Mitochondrial nucleoid interacting proteins support mitochondrial protein synthesis. Nucleic Acids Res. 2012; 40(13):6109-21. PMC: 3401451. DOI: 10.1093/nar/gks266. View

10.

Jesina P, Tesarova M, Fornuskova D, Vojtiskova A, Pecina P, Kaplanova V . Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206. Biochem J. 2004; 383(Pt. 3):561-71. PMC: 1133750. DOI: 10.1042/BJ20040407. View

11.

Arguello T, Peralta S, Antonicka H, Gaidosh G, Diaz F, Tu Y . ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly. Cell Rep. 2021; 37(12):110139. PMC: 8785211. DOI: 10.1016/j.celrep.2021.110139. View

12.

Gilquin B, Taillebourg E, Cherradi N, Hubstenberger A, Gay O, Merle N . The AAA+ ATPase ATAD3A controls mitochondrial dynamics at the interface of the inner and outer membranes. Mol Cell Biol. 2010; 30(8):1984-96. PMC: 2849464. DOI: 10.1128/MCB.00007-10. View

13.

Rone M, Midzak A, Issop L, Rammouz G, Jagannathan S, Fan J . Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol Endocrinol. 2012; 26(11):1868-82. PMC: 5416962. DOI: 10.1210/me.2012-1159. View

14.

Dorison N, Gaignard P, Bayot A, Gelot A, Becker P, Fourati S . Mitochondrial dysfunction caused by novel ATAD3A mutations. Mol Genet Metab. 2020; 131(1-2):107-113. DOI: 10.1016/j.ymgme.2020.09.002. View

15.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

16.

Cooper H, Yang Y, Ylikallio E, Khairullin R, Woldegebriel R, Lin K . ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia. Hum Mol Genet. 2017; 26(8):1432-1443. PMC: 5393146. DOI: 10.1093/hmg/ddx042. View

17.

Yap Z, Park Y, Wortmann S, Gunning A, Ezer S, Lee S . Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes. Genome Med. 2021; 13(1):55. PMC: 8042885. DOI: 10.1186/s13073-021-00873-3. View

18.

Jin G, Xu C, Zhang X, Long J, Rezaeian A, Liu C . Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells. Nat Immunol. 2017; 19(1):29-40. PMC: 5905408. DOI: 10.1038/s41590-017-0002-1. View

19.

Miller J, Enemark E . Fundamental Characteristics of AAA+ Protein Family Structure and Function. Archaea. 2016; 2016:9294307. PMC: 5039278. DOI: 10.1155/2016/9294307. View

20.

Schagger H, von Jagow G . Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem. 1991; 199(2):223-31. DOI: 10.1016/0003-2697(91)90094-a. View